Megan E. Miller, Ph.D.
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Google:
"Megan Miller"Mean distance: 19.15 (cluster 11)
Parents
Sign in to add mentor| Kay Lund | grad student | 2002 | UNC Chapel Hill | |
| (The role of suppressors of cytokine signaling in the actions of growth hormone on the intestine during parenteral nutrition.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fruchtman S, Simmons JG, Michaylira CZ, et al. (2005) Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 289: G342-50 |
| Miller ME, Michaylira CZ, Simmons JG, et al. (2004) Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology. 127: 570-81 |
| Dahly EM, Miller ME, Lund PK, et al. (2004) Postreceptor resistance to exogenous growth hormone exists in the jejunal mucosa of parenterally fed rats. The Journal of Nutrition. 134: 530-7 |
| Greenhalgh CJ, Miller ME, Hilton DJ, et al. (2002) Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease. Gastroenterology. 123: 2064-81 |
| Miller M, Simmons J, Ney D, et al. (2001) Suppressor of cytokine signaling-2 (SOCS-2) may limit GH-induced intestinal mucosal collagen synthesis Gastroenterology. 120 |
| Miller ME, Goebel HN, Williams KL, et al. (2000) Suppressor of cytokine signaling-3 (SOCS-3) mRNA is preferentially induced during experimental enterocolitis, ulcerative colitis and Crohn's disease Regulatory Peptides. 94: 67 |
| Williams KL, Miller ME, DaCosta CM, et al. (2000) Evidence for inhibition of cytokine action by growth hormone during recovery from experimental enterocolitis Regulatory Peptides. 94: 20 |